Membrane Trafficking of Renal Ion Transport Proteins in Potassium Homeostasis
钾稳态中肾离子转运蛋白的膜运输
基本信息
- 批准号:8725134
- 负责人:
- 金额:$ 46.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-06-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdrenalectomyAffectAldosteroneApicalBladder ControlBloodCarrier ProteinsCellsDietDietary intakeDiseaseDistalDiureticsDown-RegulationElectrolytesElementsEmbryoExcretory functionGene MutationGlucocorticoidsGoalsHeart DiseasesHomeostasisHypertensionIn VitroInfusion proceduresIntakeIon TransportKCNJ1 geneKidneyKidney DiseasesKnockout MiceLeadLengthMeasuresMediatingMembrane Protein TrafficMusMutant Strains MiceMyopathyNephronsOperative Surgical ProceduresPathway interactionsPhosphorylationPhosphotransferasesPhysiologicalPhysiologyPlasmaPlayPotassiumPotassium ChannelProtein KinaseRNA SplicingRegulationRelative (related person)ReportingResearchRodentRoleStaining methodStainsTestingTranscriptType II PseudohypoaldosteronismUp-RegulationVariantWestern Blottingbasedensitydriving forceepithelial Na+ channelhyperkalemiain vivoinsightmouse modeloperationoverexpressionpromoterresearch studyresponseurinary
项目摘要
DESCRIPTION (provided by applicant): The kidney adjusts K+ secretion in the distal nephron in response to variations in dietary intake to maintain K+ homeostasis. The distal K+ secretion involves K+ efflux from the cell into the lumen through apical K+ channels such as ROMK. Na+ reabsorption via the epithelial Na+ channel ENaC provides the electrical driving force for K+ secretion. An increase in the activity of the Na-Cl cotransporter NCC may decrease Na+ delivery to ENaC thus diminishing K+ secretion. In support for the role of NCC as well as ROMK in maintaining K+ homeostasis during dietary variations of K+ intake, high K+ loading in rodents increases the density of ROMK while decreasing the density of NCC in the distal nephron. The upstream regulation of ROMK and NCC remains incompletely understood. WNK1 is a protein kinase of which gene mutations resulting in increased expression cause pseudohypoaldosteronism type II (PHA2), an autosomal-dominant disease characterized by hypertension and hyperkalemia. WNK1 has several alternatively spliced variants including a ubiquitous full- length long WNK1 (L-WNK1) and a shorter kidney-specific WNK1 (KS-WNK1). Cell-based expression studies have shown that L-WNK1 activates NCC and inhibits ROMK. KS-WNK1, by itself, does not regulate NCC and ROMK but reverses L-WNK1-mediated activation and inhibition of NCC and ROMK, respectively. The long- term goal of our research is to understand K+ homeostasis in the normal physiology and in diseased states. Here, we will examine three specific aims. Aim 1 is to examine the physiological role and mechanism of L- WNK1 in the regulation of renal Na+ and K+ transport. Aim 2 is to examine the hypothesis that KS-WNK1 antagonizes L-WNK1 regulation of renal Na+ and K+ transport and changes in dietary K+ affect the ratio of L- over KS-WNK1 to regulate NCC and ROMK. Aim 3 is to examine the interplay between aldosterone and L- and KS-WNK1 pathway in the regulation of renal Na+ and K+ transport and the response to variations in dietary K+. We have generated mouse models with genetically altered expression of L-and/or KS-WNK1. Renal Na+ and K+ transport in these mice will be studied by measuring blood and urinary electrolytes and expression of Na+ and K+ transporters in response to dietary Na+ or K+ perturbations and to diuretics. K+ secretion will also be studied by in vitro microperfusion of isolated CCD tubules. Surgical adrenalectomy will be performed to examine interactions between aldosterone and WNK1 pathway. These studies will provide important insights to the in vivo role of WNK1 in renal Na+ and K+ transport in the normal physiology and in diseased states.
描述(由申请人提供):肾脏会根据饮食摄入的变化以维持K+体内稳态的变化,调整远端肾单位的K+分泌。远端K+分泌涉及通过顶端K+通道(例如ROMK)从细胞进入管腔的K+外排。 Na+通过上皮Na+通道ENAC的吸收可为K+分泌提供电驱动力。 Na-Cl共转运蛋白NCC的活性增加可能会降低Na+递送到ENAC,从而减少K+分泌。为了支持NCC和ROMK在K+摄入饮食变化过程中保持K+稳态方面的作用,啮齿动物中的高K+负荷增加了ROMK的密度,同时降低了Nephron远端NCC的密度。 ROMK和NCC的上游调节仍然不完全理解。 WNK1是一种蛋白激酶,其基因突变导致表达增加会导致II型假甲状腺醛酸(PHA2),这是一种以高血压和高血压为特征的常染色体显性疾病。 WNK1具有多种剪接的变体,包括无处不在的全长长WNK1(L-WNK1)和较短的肾脏特异性WNK1(KS-WNK1)。基于细胞的表达研究表明,L-WNK1激活NCC并抑制ROMK。 KS-WNK1本身并不调节NCC和Romk,而是分别逆转L-WNK1介导的激活和抑制NCC和Romk。我们研究的长期目标是了解正常生理和患病状态中的K+稳态。在这里,我们将研究三个具体目标。目的1是检查L-WNK1在肾脏Na+和K+转运的调节中的生理作用和机制。 AIM 2是检查以下假设:KS-WNK1拮抗肾脏Na+和K+转运的L-WNK1调节以及饮食K+的变化会影响L-与KS-WNK1的比率相比,以调节NCC和ROMK。 AIM 3是在调节肾脏Na+和K+转运的调节中检查醛固酮和L-和KS-WNK1途径之间的相互作用,以及对饮食K+变化的反应。我们已经生成了L-and/或KS-WNK1的遗传表达的小鼠模型。这些小鼠的肾脏Na+和K+转运将通过测量血液和尿电解质以及Na+和K+转运蛋白的表达来研究,以响应饮食中的Na+或K+扰动以及对利尿剂。 K+分泌也将通过分离的CCD小管的体外微灌注来研究。将进行手术肾上腺切除术,以检查醛固酮和WNK1途径之间的相互作用。这些研究将为WNK1在正常生理和患病状态中的肾脏Na+和K+转运中的体内作用提供重要见解。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Recent advances in distal tubular potassium handling.
远端肾小管钾处理的最新进展。
- DOI:10.1152/ajprenal.00742.2010
- 发表时间:2011
- 期刊:
- 影响因子:0
- 作者:Rodan,AylinR;Cheng,Chih-Jen;Huang,Chou-Long
- 通讯作者:Huang,Chou-Long
Zebrafish WNK lysine deficient protein kinase 1 (wnk1) affects angiogenesis associated with VEGF signaling.
- DOI:10.1371/journal.pone.0106129
- 发表时间:2014
- 期刊:
- 影响因子:3.7
- 作者:Lai JG;Tsai SM;Tu HC;Chen WC;Kou FJ;Lu JW;Wang HD;Huang CL;Yuh CH
- 通讯作者:Yuh CH
A unifying mechanism for WNK kinase regulation of sodium-chloride cotransporter.
- DOI:10.1007/s00424-015-1708-2
- 发表时间:2015-11
- 期刊:
- 影响因子:0
- 作者:Huang CL;Cheng CJ
- 通讯作者:Cheng CJ
Expression and function of the epithelial sodium channel δ-subunit in human respiratory epithelial cells in vitro.
体外人呼吸道上皮细胞上皮钠通道δ亚基的表达和功能。
- DOI:10.1007/s00424-015-1693-5
- 发表时间:2015
- 期刊:
- 影响因子:0
- 作者:Schwagerus,Elena;Sladek,Svenja;Buckley,StephenT;Armas-Capote,Natalia;AlvarezdelaRosa,Diego;Harvey,BrianJ;Fischer,Horst;Illek,Beate;Huwer,Hanno;Schneider-Daum,Nicole;Lehr,Claus-Michael;Ehrhardt,Carsten
- 通讯作者:Ehrhardt,Carsten
Distal potassium handling based on flow modulation of maxi-K channel activity.
- DOI:10.1097/mnh.0b013e32832c75d8
- 发表时间:2009-07
- 期刊:
- 影响因子:3.2
- 作者:Rodan AR;Huang CL
- 通讯作者:Huang CL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chou-Long Huang其他文献
Chou-Long Huang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chou-Long Huang', 18)}}的其他基金
Regulation of Renal Calcium Transport in Health and Disease
健康和疾病中肾脏钙转运的调节
- 批准号:
9562002 - 财政年份:2017
- 资助金额:
$ 46.96万 - 项目类别:
相似国自然基金
基于下一代目标区域序列捕获测序技术的MEN2早期个体化诊疗策略研究
- 批准号:81472861
- 批准年份:2014
- 资助金额:72.0 万元
- 项目类别:面上项目
相似海外基金
A First-in-Class Human Antibody Therapeutic for Treatment of Cushing's Disease
用于治疗库欣病的一流人类抗体疗法
- 批准号:
9909906 - 财政年份:2019
- 资助金额:
$ 46.96万 - 项目类别:
Skeletal Consequences of Mild Autonomous Cortisol Secretion
轻度自主皮质醇分泌对骨骼的影响
- 批准号:
9803313 - 财政年份:2019
- 资助金额:
$ 46.96万 - 项目类别:
Skeletal Consequences of Mild Autonomous Cortisol Secretion
轻度自主皮质醇分泌对骨骼的影响
- 批准号:
10160897 - 财政年份:2019
- 资助金额:
$ 46.96万 - 项目类别:
Skeletal Consequences of Mild Autonomous Cortisol Secretion
轻度自主皮质醇分泌对骨骼的影响
- 批准号:
10405659 - 财政年份:2019
- 资助金额:
$ 46.96万 - 项目类别: